Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Cytomx Thera (CTMX)

21.57 -0.09 (-0.42%)

12-15 16:00

Open:

21.7

Pre. Close:

21.66

High:

22.12

Low:

21.51

Volume:

1,321,403

Market Cap:

828M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

22.85 - 22.96

22.96 - 23.09

Low:

19.98 - 20.45

20.45 - 21.03

Close:

20.41 - 21.18

21.18 - 22.15

Technical analysis  (as of: 2017-12-15 4:54:26 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 26.86     One year: 31.38

Support:

Support1: 20.47    Support2: 18.91

Resistance:

Resistance1: 23.00    Resistance2: 26.86

Pivot:

20.89

Moving Averages:

MA(5): 21.57     MA(20): 20.81

MA(100): 18.33     MA(250): 15.79

MACD:

MACD(12,26): 0.39     Signal(12,26,9): 0.28

%K %D:

%K(14,3): 71.48     %D(3): 73.51

RSI:

RSI(14): 58.37

52-Week:

High: 24.671  Low: 10.4  Change(%): 83.7

Average Vol(K):

3-Month: 44990  10-Days 39821

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CTMX has closed below upper band by 23.1%. Bollinger Bands are 14.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 14 Dec 2017 22:32:13 GMT
CytomX Therapeutics Inc. (CTMX) Moves Lower on Volume Spike for December 14

Wed, 13 Dec 2017 22:30:08 GMT
CytomX Therapeutics Inc. (CTMX) Soars 6.5% on December 13

Tue, 08 Aug 2017 02:26:15 GMT
CytomX Therapeutics' (CTMX) CEO Sean McCarthy on Q2 2017 Results - Earnings ...

Sun, 17 Dec 2017 00:56:15 GMT
CytomX Therapeutics, Inc. (CTMX) Position Boosted by The Manufacturers Life ...

Thu, 27 Jul 2017 12:00:00 GMT
CytomX Therapeutics to Announce Second Quarter 2017 Financial Results and ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

38.41

Shares Float (M)

29.67

% Held by Insiders

7.60

% Held by Institutions

78.71

Shares Short (K)

1100

Shares Short Prior Month (K)

1250

Stock Financials

EPS

-1.580

EPS Est. Current Year

-1.490

EPS Est. Next Year

-1.410

EPS Est. Next Quarter

-0.410

Forward EPS

-1.530

Book Value (p.s.)

1.230

PEG Ratio

-6.90

Profit Margin

-113.64

Operating Margin

-116.57

Return on Assets (ttm)

-12.8

Return on Equity (ttm)

-85.6

Qtrly Rev. Growth

599.0

Gross Profit (p.s.)

0.392

Sales Per Share

EBITDA (p.s.)

-1.500

Qtrly Earnings Growth

Operating Cash Flow (M)

150.31

Levered Free Cash Flow (M)

-19.81

atoplab.com

Valuation

P/E

-13.65

P/E Growth Ratio

P/BV

17.54

P/S

596045824.00

P/CF

5.51

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.